The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SM-88 therapy in high risk poor prognosis pancreatic cancer (PDAC).
 
Marcus Smith Noel
Consulting or Advisory Role - Celgene; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Taiho Pharmaceutical
 
Andrea Wang-Gillam
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Jacobio; Merrimack; Vicus Therapeutics
Research Funding - Abbvie (Inst); Aduro Biotech (Inst); AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); CTI (Inst); EMD Serono (Inst); Halozyme (Inst); Lilly (Inst); Merck (Inst); Newlink Genetics (Inst); pfizer (Inst); Plexxikon (Inst); Precision Therapeutics (Inst); Roche (Inst); Verastem (Inst); Xcovery (Inst)
 
Allyson J. Ocean
No Relationships to Disclose
 
Sant P. Chawla
Honoraria - Amgen; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; Janssen; Karyopharm Therapeutics; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Consulting or Advisory Role - Amgen; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; Janssen; Karyopharm Therapeutics; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Speakers' Bureau - Amgen; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; Janssen; Karyopharm Therapeutics; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Research Funding - Amgen; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; Janssen; Janssen; Karyopharm Therapeutics; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
 
Vincent Chung
Consulting or Advisory Role - Celgene; Five Prime Therapeutics; Ipsen; Perthera
Speakers' Bureau - AstraZeneca; Celgene; Ipsen
 
Giuseppe Del Priore
Employment - TYME
Leadership - TYME
Stock and Other Ownership Interests - TYME
Consulting or Advisory Role - TYME
 
Vincent J. Picozzi
Stock and Other Ownership Interests - Abbvie; Amgen; Gilead Sciences; Johnson & Johnson
Consulting or Advisory Role - Abbvie; Cornerstone Pharmaceuticals; Gilead Sciences; Halozyme
Research Funding - Aduro Biotech; Celgene; FibroGen; Immunomedics; OncoMed